DENVER, July 24, 2025 /PRNewswire/ -- Korsail Energy, a leading renewable energy developer announced today the release of its newly enhanced Community Engagement Guidelines...
DALLAS, July 24, 2025 (GLOBE NEWSWIRE) -- Dorchester Minerals, L.P. (NASDAQ:DMLP) announced today the Partnership’s second quarter 2025 cash distribution. The distribution of $0.620216 per common unit represents activity for the three-month period ended June 30, 2025 and is payable on August 14, 2025 to common unitholders of record as of August 4, 2025.
RAPID CITY, S.D., July 24, 2025 (GLOBE NEWSWIRE) -- Black Hills Corp. (NYSE: BKH) today announced that its natural gas utility subsidiary in Kansas received approval from the Kansas Corporation Commission of a unanimous settlement agreement for new rates. The new rates will provide recovery of approximately $118 million of system investments since the utility’s last general rate filing in 2021 and inflationary impacts on costs of delivering safe and reliable natural gas service.
Plan Confirmation and Sale Approval Court Date Expected in Early September
GAINESVILLE, Fla., July 24, 2025 /PRNewswire/ -- Exactech, a global medical technology leader, has filed...
WINTER HAVEN, Fla., July 24, 2025 /PRNewswire/ -- SouthState Corporation ("SouthState" or the "Company") (NYSE: SSB) today released its unaudited results of operations and...
Alpha Ladder Finance's NFDT framework bridges physical assets and digital finance, creating a unique and transparent digital representation of live real-world assets, and enabling...
METTAWA, Ill., July 24, 2025 (GLOBE NEWSWIRE) -- Brunswick Corporation (NYSE: BC), today, released its second quarter 2025 financial results. A complete and full-text financial results press release is available on the Company’s website at https://ir.brunswick.com. The results will also be available on the SEC’s website with the Form 8-K filing of the release at http://goo.gl/wJQN1.
Wuppertal, Germany, July 24, 2025 - Aicuris Anti-infective Cures AG today announced the completion of patient enrollment in its pivotal Phase 3 trial, PRIOH-1, evaluating pritelivir for the treatment of refractory and/or treatment resistant herpes simplex virus (HSV) infections in immunocompromised patients. The company’s lead candidate is a small molecule specifically inhibiting the viral helicase-primase complex, which represents a novel mechanism of action distinct from current HSV therapies.
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Semler (SMLR), GoHealth (GOCO), or Cleveland-Cliffs (CLF) To Contact Him Directly To Discuss Their Options
CHICAGO, July 22, 2025 /PRNewswire/ -- Today, McDonald's Board of Directors declared a quarterly cash dividend of $1.77 per share of common stock payable...
BOCA RATON, FL, July 22, 2025 (GLOBE NEWSWIRE) -- CORRECTED: The originally reported SOL purchase amount was overstated by 1,000 SOL, and organic growth was understated by 1,000 SOL. These figures have been updated below to reflect the correct totals. No changes to our total SOL holdings or SPS.